"To avoid sharing precious food resources with other micro-organisms such as fungi, the carnivorous plant has developed a host of agents that act as natural anti-fungal agents," says Aviah Zilberstein of Tel Aviv University's Department of Plant Sciences. "In the natural habitat of the tropics, competition for food is fierce, and the hot, moist environment is perfect for fungi, which would also love to eat the plant's insect meal."
After initial tests of the plant proteins and enzymes that dissolve the chitin of fungi, Prof. Zilberstein assumes that, in the right clinical conditions, the pitcher secondary metabolites can be developed to effective anti-fungal drugs, that may avoid the evolution of new resistant infective strains.
Currently there is a need for additional broadly effective anti-fungal drugs. Even mildly severe forms of athlete's foot or other skin fungal infections lack effective treatments. The problem becomes more dire at hospitals, where thousands of Americans die each year from secondary fungal infections they acquire during their stay as patients.
Forging a "wild" pathway in drug discovery
The collaborating team has determined plant secondary metabolites that function as anti-fungal agents. "The pitcher of the carnivorous plant produces these compounds in a gland," says Prof. Zilberstein. Until now, no one has published or discussed the anti-fungal metabolites found in the trap liquid of this plant, she says.
"We're hoping that these metabolites are working together to keep fungus at bay. Our aim now is to get funding for pre-clinical tests of these compounds in an animal model, so we can investigate their effectiveness against the two very acute fungal pathogens found in hospitals worldwide," she says.
The idea that liquid from a plant pitcher could stave off infection has been documented in the folk literature of India, where people drink carnivorous plant pitcher juice as a general elixir. "There is a lot of room for developing compounds from nature into new drugs," says Prof. Zilberstein. "The one we are working on is not toxic to humans. Now we hope to show how this very natural product can be further developed as a means to overcome some basic problems in hospitals all over the world."
- Why I Wasn't Excited About That Medieval Remedy For MRSA
- Janssen Submits Applications Requesting Approval Of SIMPONI® In U.S. And Europe For Treatment Of Ulcerative Colitis
- Resveratrol: The Compound Behind All Those 'Red Wine Is Good For You' Stories
- 10-Year Data Evaluating Adalimumab For Patients With Moderate-to-Severe Rheumatoid Arthritis
- I Am Going Nuts, Really